Shilpa Medicare arm gets CEP from EDQM for Desmopressin

Shilpa Medicare informed that its 100% subsidiary, Shilpa Pharma Lifesciences received certificate of suitability (CEP) from EDQM (European Directorate for the Quality of Medicines & Healthcare) for API, Desmopressin.